Loading...
XSHE000423
Market cap5.49bUSD
Dec 26, Last price  
62.36CNY
1D
-1.36%
1Q
5.50%
Jan 2017
15.76%
Name

Dong-E-E-Jiao Co Ltd

Chart & Performance

D1W1MN
XSHE:000423 chart
P/E
34.81
P/S
8.50
EPS
1.79
Div Yield, %
1.89%
Shrs. gr., 5y
-0.33%
Rev. gr., 5y
-8.47%
Revenues
4.72b
+16.66%
881,345,641938,172,2761,069,373,2631,381,360,6751,685,955,3112,079,106,0812,463,784,2682,758,848,2533,056,074,2634,016,304,4154,009,010,4685,449,663,1576,317,135,2867,372,340,3327,338,316,2232,958,622,3393,409,437,1643,848,985,6864,041,818,3474,715,265,729
Net income
1.15b
+47.55%
131,393,370109,691,712153,855,462205,804,808287,044,651392,123,976582,224,299856,166,1701,040,218,1411,202,878,2241,365,547,7901,625,027,0311,852,473,5182,044,352,5032,084,866,052043,289,251440,439,963779,998,1161,150,878,550
CFO
1.95b
-8.93%
137,188,52667,407,174311,882,903240,331,283296,834,367812,705,828635,765,908709,731,461858,044,198879,093,682657,105,721977,610,166624,572,5121,757,389,2101,009,049,0530800,834,1832,800,902,5282,144,878,1851,953,438,009
Dividend
Sep 10, 20241.14669 CNY/sh
Earnings
Mar 20, 2025

Profile

Dong-E-E-Jiao Co.,Ltd. produces and sells traditional Chinese medicines, biological drugs, and health food products in China. Dong-E-E-Jiao Co.,Ltd. was founded in 1952 and is based in Liaocheng, China.
URL
https://www.dongeejiao.com/
IPO date
Jul 29, 1996
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
4,715,266
16.66%
4,041,818
5.01%
3,848,986
12.89%
Cost of revenue
3,120,865
2,795,800
2,692,850
Unusual Expense (Income)
NOPBT
1,594,401
1,246,018
1,156,135
NOPBT Margin
33.81%
30.83%
30.04%
Operating Taxes
210,945
132,788
132,155
Tax Rate
13.23%
10.66%
11.43%
NOPAT
1,383,456
1,113,231
1,023,981
Net income
1,150,879
47.55%
779,998
77.10%
440,440
917.43%
Dividends
(758,665)
(425,114)
(191,733)
Dividend yield
2.39%
1.62%
0.61%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
24,029
18,181
Long-term debt
62,046
84,889
95,160
Deferred revenue
65,741
75,838
89,613
Other long-term liabilities
57,347
57,954
62,237
Net debt
(5,849,158)
(7,121,891)
(5,601,841)
Cash flow
Cash from operating activities
1,953,438
2,144,878
2,800,903
CAPEX
(54,450)
Cash from investing activities
(718,144)
589,508
Cash from financing activities
(778,982)
FCF
1,995,602
2,236,353
3,501,864
Balance
Cash
8,336,771
7,230,809
5,715,183
Long term investments
(2,425,568)
Excess cash
5,675,441
7,028,718
5,522,733
Stockholders' equity
9,874,090
10,002,832
9,647,412
Invested Capital
5,219,233
3,354,216
4,498,556
ROIC
32.27%
28.35%
17.59%
ROCE
14.63%
12.00%
11.54%
EV
Common stock shares outstanding
642,949
643,977
643,977
Price
49.32
21.18%
40.70
-16.51%
48.75
25.94%
Market cap
31,710,240
20.99%
26,209,857
-16.51%
31,393,870
25.75%
EV
25,882,630
19,109,513
25,814,351
EBITDA
1,758,246
1,413,253
1,318,009
EV/EBITDA
14.72
13.52
19.59
Interest
3,973
5,177
5,704
Interest/NOPBT
0.25%
0.42%
0.49%